US Stock MarketDetailed Quotes

VYNE VYNE Therapeutics

Watchlist
  • 2.9600
  • +0.0100+0.34%
Close Nov 29 13:00 ET
  • 2.9600
  • 0.00000.00%
Post 17:01 ET
43.66MMarket Cap0.87P/E (TTM)

About VYNE Therapeutics Company

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded in October 2011 and is headquartered in Bridgewater, NJ.

Company Profile

SymbolVYNE
Company NameVYNE Therapeutics
Listing DateJan 25, 2018
Issue Price17.00
Founded2011
CEOMr. David Domzalski
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address685 Route 202/206 North,Suite 301
CityBridgewater
ProvinceNew Jersey
CountryUnited States of America
Zip Code08807
Phone1-800-755-7936
Websitehttp://www.vynetherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • David Domzalski
  • President, Chief Executive Officer and Director
  • 2.72M
  • Dr. Iain A. Stuart, PhD
  • Chief Scientific Officer
  • 1.16M
  • Tyler Zeronda
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • --
  • Mutya Harsch
  • General Counsel, Chief Legal Officer and Secretary
  • 1.13M
  • Dr. Christine Borowski, PhD
  • Independent Director
  • --
  • Sharon Barbari
  • Independent Director
  • 116.10K
  • Steven L. Basta
  • Independent Director
  • 83.60K
  • Elisabeth A. Sandoval Little
  • Independent Director
  • 108.60K
  • Anthony D Bruno
  • Independent Director
  • 101.10K
  • Patrick G. LePore
  • Lead Independent Director
  • 123.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data